JPMorgan Chase & Co’s Gyre Therapeutics GYRE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$47.5K Buy
6,461
+2,961
+85% +$21.8K ﹤0.01% 5116
2025
Q1
$27K Buy
3,500
+231
+7% +$1.78K ﹤0.01% 5204
2024
Q4
$39.6K Buy
3,269
+237
+8% +$2.87K ﹤0.01% 5084
2024
Q3
$38K Buy
3,032
+57
+2% +$715 ﹤0.01% 5055
2024
Q2
$35.5K Sell
2,975
-17,053
-85% -$203K ﹤0.01% 5014
2024
Q1
$350K Buy
20,028
+19,736
+6,759% +$345K ﹤0.01% 4160
2023
Q4
$7.5K Sell
292
-178
-38% -$4.57K ﹤0.01% 5458
2023
Q3
$3.4K Buy
470
+467
+15,567% +$3.38K ﹤0.01% 5492
2023
Q2
$18 Hold
3
﹤0.01% 5886
2023
Q1
$0 Sell
3
-4
-57% ﹤0.01% 5944
2022
Q4
$0 Hold
7
﹤0.01% 5729
2022
Q3
$0 Hold
7
﹤0.01% 5640
2022
Q2
$0 Sell
7
-404
-98% ﹤0.01% 5724
2022
Q1
$2K Buy
411
+404
+5,771% +$1.97K ﹤0.01% 5590
2021
Q4
$0 Sell
7
-4,141
-100% ﹤0.01% 5787
2021
Q3
$128K Sell
4,148
-7,185
-63% -$222K ﹤0.01% 4600
2021
Q2
$368K Sell
11,333
-5,596
-33% -$182K ﹤0.01% 4169
2021
Q1
$640K Buy
16,929
+5,757
+52% +$218K ﹤0.01% 3910
2020
Q4
$529K Buy
11,172
+4,233
+61% +$200K ﹤0.01% 3712
2020
Q3
$227K Buy
6,939
+3,811
+122% +$125K ﹤0.01% 3681
2020
Q2
$137K Buy
+3,128
New +$137K ﹤0.01% 3827
2020
Q1
Sell
-1,992
Closed -$102K 4720
2019
Q4
$102K Sell
1,992
-19,421
-91% -$994K ﹤0.01% 4014
2019
Q3
$789K Sell
21,413
-8,152
-28% -$300K ﹤0.01% 3167
2019
Q2
$1.7M Sell
29,565
-895
-3% -$51.5K ﹤0.01% 2758
2019
Q1
$1.85M Buy
30,460
+11,599
+61% +$706K ﹤0.01% 2677
2018
Q4
$1.12M Buy
18,861
+10,035
+114% +$594K ﹤0.01% 2978
2018
Q3
$714K Buy
8,826
+8,412
+2,032% +$681K ﹤0.01% 3333
2018
Q2
$36K Buy
+414
New +$36K ﹤0.01% 4412
2014
Q4
Sell
-20
Closed -$39K 3429
2014
Q3
$39K Buy
+20
New +$39K ﹤0.01% 3365
2013
Q4
Sell
-30
Closed -$128K 3674
2013
Q3
$128K Buy
30
+3
+11% +$12.8K ﹤0.01% 3739
2013
Q2
$92K Buy
+27
New +$92K ﹤0.01% 3698